Connect with us

Technology

Trenbolone Enanthate Market size is set to grow by USD 13.4 million from 2024-2028, Health benefits of using anabolic steroids boost the market, Technavio

Published

on

NEW YORK, July 15, 2024 /PRNewswire/ — The global trenbolone enanthate market size is estimated to grow by USD 13.4 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  3.21%  during the forecast period. Health benefits of using anabolic steroids is driving market growth, with a trend towards emergence of e-commerce platform. However, side effects of trenbolone enanthate  poses a challenge. Key market players include Alpha Pharma Healthcare, Dragon Pharma, Genesis Pharmaceuticals Ltd., Kalpa Pharmaceuticals, Labdhi Pharmaceuticals LLP, and SP Laboratory.

Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report

Trenbolone Enanthate Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 3.21%

Market growth 2024-2028

USD 13.4 million

Market structure

Concentrated

YoY growth 2022-2023 (%)

3.06

Regional analysis

North America, Europe, APAC, South America, and Middle East and Africa

Performing market contribution

Europe at 46%

Key countries

US, Germany, China, Canada, and Brazil

Key companies profiled

Alpha Pharma Healthcare, Dragon Pharma, Genesis Pharmaceuticals Ltd., Kalpa Pharmaceuticals, Labdhi Pharmaceuticals LLP, and SP Laboratory

Market Driver

The global trenbolone enanthate market has experienced significant growth with the emergence of e-commerce platforms. Trenbolone enanthate, a popular steroid among bodybuilders and athletes, can now be easily purchased through these online marketplaces. Consumers benefit from a wide range of options, enabling them to compare prices and features before making a purchase. E-commerce platforms like Amazon, eBay, Alibaba, and Rakuten offer consumers the convenience of purchasing from anywhere in the world, making it easier to access hard-to-find products. These platforms contribute positively to the growth of the global trenbolone enanthate market, providing a seamless shopping experience for consumers. 

Trenbolone Enanthate, an anabolic steroid, is a popular choice among bodybuilders and athletes for its ability to build muscle mass, increase strength, and boost metabolic rate. This steroid is particularly effective for those over 30, as it helps combat the natural decline in skeletal muscle and physical performance associated with aging. Trenbolone Enanthate also has psychological benefits, including improved mood and motivation. However, it’s essential to note that Trenbolone Enanthate has reproductive health impacts, including androgenic effects such as body hair growth and acne. Dosages vary, with injections being the most common route of administration, but oral pills and even powder forms are available through various channels, including retail pharmacies, online pharmacies, underground labs, and e-commerce sites. This steroid is also used in veterinary applications for weight gain and performance enhancement in livestock. New drugs and therapies are constantly emerging, but Trenbolone Enanthate remains a sought-after performance-enhancing substance. Be aware that the use of illicit steroids, including Trenbolone Enanthate, can have serious health risks and legal consequences. Always consult a healthcare professional before use. 

Discover 360° analysis of this market. For complete information, schedule your consultation – Book Here!

Market Challenges

The trenbolone enanthate market faces significant limitations due to the drug’s potential side effects. Long-term use of this anabolic steroid can lead to dependence, baldness, acne, excessive sweating, increased blood pressure, and suppressed natural testosterone production. Additionally, trenbolone enanthate can negatively impact heart health by reducing HDL cholesterol levels, which is essential for lowering cholesterol. Furthermore, users may experience swelling of ankles, breast enlargement in men, smaller testicles, and prostate stimulation. Women may experience changes in their menstrual cycle, vaginal dryness, and a decrease in breast size with prolonged use. These side effects hinder the expansion of the global trenbolone enanthate market during the forecast period.Trenbolone Enanthate is a popular anabolic androgenic steroid (AAS) used in various applications due to its unique properties. In pharmaceutical industry, it’s used for hormone replacement therapies in conditions like primary and hypogonadotropic hypogonadism, delayed puberty, and metastatic breast cancer. In fitness and bodybuilding, it’s sought after for muscle wasting conditions, hormonal imbalances, and to enhance physical appearance, athletic performance, and strength gains. In gym facilities and fitness activities, bodybuilders use it for lean muscle mass, protein synthesis, nutrient partitioning effects, and mineral absorption. For livestock, it’s used to improve muscle growth and efficiency. However, challenges exist in its use. These include monitoring training frequency and AAS dose, potential side effects like anxiety, insomnia, and aggression, and ethical considerations in sports. Moreover, obesity, chronic wasting diseases, osteoporosis, and testosterone hormone deficiency are growing health concerns. Trenbolone Enanthate can help address some of these issues, but proper medical supervision is crucial due to potential risks and interactions with other medications. Younger generations, fitness bloggers, and athletes are increasingly turning to AAS for quick results, but education about proper use and potential risks is essential. Overall, Trenbolone Enanthate offers significant benefits, but careful consideration and expert guidance are necessary to ensure safe and effective use.

For more insights on driver and challenges – Request a sample report!

Segment Overview 

This trenbolone enanthate market report extensively covers market segmentation by  

Type 1.1 Oral1.2 InjectableApplication 2.1 Bodybuilding2.2 Medical2.3 VeterinaryGeography 3.1 North America3.2 Europe3.3 APAC3.4 South America3.5 Middle East and Africa

1.1 Oral-  Trenbolone Enanthate is a popular anabolic steroid in the bodybuilding community. This steroid is known for its ability to promote muscle growth and increase strength. The market for Trenbolone Enanthate has been growing steadily due to its effectiveness. Suppliers and manufacturers produce this steroid in various forms, including injectable solutions and tablets. Its demand remains high among bodybuilders and athletes seeking to enhance their performance and physique. Despite some potential side effects, the demand for Trenbolone Enanthate continues to increase, making it a significant product in the steroid market.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) – Download a Sample Report

Learn and explore more about Technavio’s in-depth research reports

The global osteoporosis drugs market is experiencing significant growth due to rising geriatric populations and increased awareness of bone health. Key players are investing in innovative treatments to address the increasing incidence of osteoporosis, driving market expansion.

The global sinus dilation devices market is expanding rapidly, driven by the prevalence of chronic sinusitis and advancements in minimally invasive procedures. Technological innovations in balloon sinuplasty and other dilation techniques are enhancing patient outcomes and boosting market growth, with key players focusing on product development and strategic partnerships.

Research Analysis

Trenbolone Enanthate is a popular anabolic steroid among bodybuilders and athletes for its ability to promote muscle mass, strength gains, and fat loss. This steroid is known for its strong androgenic properties, which can lead to increased vascularity, muscle hardness, and masculinization. However, it also comes with potential side effects such as water retention, anxiety, insomnia, and aggression. Bodybuilders and fitness enthusiasts often use Trenbolone Enanthate in their training regimens to enhance their physical appearance and athletic performance. The steroid can help increase muscle mass, improve strength, and boost metabolic rate, making it an attractive option for those looking to gain an edge in the gym. However, it’s important to note that the use of anabolic androgenic steroids like Trenbolone Enanthate comes with risks. Users may experience side effects such as anxiety, insomnia, and aggression, and long-term use can lead to health issues such as cardiovascular problems and liver damage. To minimize the risks, it’s recommended to use Trenbolone Enanthate under medical supervision and follow a proper training and diet plan. Training frequency, AAS dose, and fitness level are all important factors to consider when using this steroid. Ultimately, the decision to use Trenbolone Enanthate should be based on individual goals, risks, and benefits. In summary, Trenbolone Enanthate is a potent anabolic steroid used by bodybuilders and athletes to enhance muscle mass, strength gains, and fat loss. However, it comes with potential side effects and risks, making it essential to use it responsibly and under medical supervision.

Market Research Overview

Trenbolone Enanthate is a popular anabolic steroid among bodybuilders and athletes for its ability to build muscle mass and improve physical performance. This injectable steroid is known for its effectiveness in promoting lean muscle growth, enhancing vascularity, and increasing muscle hardness. Trenbolone Enanthate works by increasing protein synthesis, nutrient partitioning, and mineral absorption, making it an essential tool for those seeking to maximize their fitness gains. The steroid is available in various forms, including powder and injectable solutions, and can be purchased from various sources such as online pharmacies, underground labs, and e-commerce channels. Trenbolone Enanthate is also used in pharmaceutical applications, including hormone replacement therapies and treatments for muscle wasting conditions and hormonal imbalances. The use of Trenbolone Enanthate extends beyond bodybuilding and athletic circles, with applications in veterinary medicine and livestock farming. However, its use comes with potential side effects, including water retention, anxiety, insomnia, aggression, and reproductive health impacts. Despite its benefits, the use of Trenbolone Enanthate and other anabolic steroids is controversial, with many young people and fitness bloggers turning to them for quick gains. The use of illicit steroids can lead to chronic wasting diseases, obesity, osteoporosis, and other health issues. It is essential to consider the potential risks and consult a healthcare professional before using Trenbolone Enanthate or any other performance-enhancing substance.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

TypeOralInjectableApplicationBodybuildingMedicalVeterinaryGeographyNorth AmericaEuropeAPACSouth AmericaMiddle East And Africa

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/trenbolone-enanthate-market-size-is-set-to-grow-by-usd-13-4-million-from-2024-2028–health-benefits-of-using-anabolic-steroids-boost-the-market-technavio-302196425.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Reliance Digital Brings Samsung’s Latest Galaxy Z Fold8 Series and Galaxy Z Flip8 to Stores Across India

Published

on

By

Be among the first to own the new Samsung Galaxy Z Fold8 series and Galaxy Z Flip8. Customers can now pre-order the latest Galaxy foldables at Reliance Digital, with EMIs starting at ₹6000/month.

MUMBAI, India, July 25, 2026 /PRNewswire/ — Reliance Digital, India’s leading consumer electronics retailer, today announced the availability of Samsung’s latest generation of foldable smartphones – the Galaxy Z Fold8 Ultra, Galaxy Z Fold8 and Galaxy Z Flip8. Designed to deliver the next evolution of Galaxy AI, powerful performance and iconic foldable innovation, Samsung’s newest line-up is now available across Reliance Digital stores and online.

Built around Samsung’s vision of making AI more intuitive and personal, the new Galaxy foldables combine immersive displays, premium craftsmanship and intelligent experiences that seamlessly adapt to the way users work, create and stay connected.

Leading the line-up is the Galaxy Z Fold8 Ultra, Samsung’s most premium foldable yet. Featuring an expansive 8-inch Dynamic AMOLED 2X main display, a flagship 200MP camera, the latest Snapdragon® 8 Elite Gen 5 for Galaxy processor and a 5,000mAh battery, the device is engineered for users who demand the ultimate in productivity, creativity and entertainment. It is available in Graphite, Cream and Violet Shadow,.

The Galaxy Z Fold8 brings Samsung’s signature foldable experience in a more compact form factor, featuring a 7.6-inch Dynamic AMOLED 2X main display, a redesigned wider cover screen, Galaxy AI-powered multitasking and flagship-grade performance. Customers can choose from Lavender, Graphite and Cream colour options.

Completing the line-up is the Galaxy Z Flip8, Samsung’s most stylish foldable smartphone, designed for users who want flagship performance in a compact, pocket-friendly form. Equipped with a vibrant 6.9-inch Dynamic AMOLED 2X display, an enhanced FlexWindow, a 50MP camera system and Galaxy AI experiences, the Flip8 effortlessly blends fashion with functionality.

Customers can visit their nearest Reliance Digital store to experience the new foldables first-hand with guidance from Reliance Digital’s Tech Dosts, compare models, explore exclusive launch offers and Pre-order the Galaxy device that best fits their lifestyle. The complete Galaxy Z Fold8 series and Galaxy Z Flip8 are also available through Reliance Digital’s online platform, ensuring customers can be among the first to own Samsung’s latest foldable innovations.

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/reliance-digital-brings-samsungs-latest-galaxy-z-fold8-series-and-galaxy-z-flip8-to-stores-across-india-302834321.html

Continue Reading

Technology

Weichai’s Five Tech Routes Global Debut: Diverse Paths to a Green, Smart Future

Published

on

By

HANOI, Vietnam, July 25, 2026 /PRNewswire/ — At VEC in Vietnam on July 21, the Shandong Heavy Industry global partners conference & green intelligent products expo opened. Responding to the green transition of global commercial vehicles and heavy equipment, Weichai – with decades of expertise – unveiled five core tech routes: BEV, HEV, PEMFC, alternative-fuel ICE, and ADAS. Through full-chain proprietary control and breakthroughs, it provides efficient, low-carbon, intelligent power solutions to the global market.

Battery electric vehicle powertrain: full-chain deployment and high-efficiency recharging: Weichai masters core battery, motor, and e‑control technologies. Its CT100 battery – for heavy tractors and dump trucks – features integrated design and triple insulation, delivering better reliability, efficiency, safety, and speed. The WMS3200 drive system, tailored for heavy‑truck haulage, boosts efficiency and cuts vehicle power consumption. The WMC‑L/H/B integrated controllers offer stable, efficient control for light trucks, heavy trucks, and buses.

Hybrid electric vehicle powertrain: deep integration and ultra-long range: Weichai covers series, parallel, and series-parallel architectures, deeply integrating engine and e-drive. For urban logistics, the WP2.5T range extender offers quick response and low noise; for long-haul transport, the WP3NNG natural-gas range extender uses a “pure electric for short hauls, range-extended for long hauls” mode, with over 1,000 km combined range, easing range anxiety.

Proton exchange membrane fuel cell: zero-carbon leadership: Weichai has built a full-chain hydrogen energy system covering components, stacks, and systems. The WEF300 fuel cell engine has been deployed in volume in 49-ton heavy-duty trucks, suitable for long-haul and port logistics. The WEFG500 power generation system provides megawatt-class scalable power to support data centers and industrial plants.

Alternative fuel internal combustion engine: diverse clean-energy options and exceptional cost-effectiveness: Modular design enables flexible switching between H₂ and methanol. WP15DI hydrogen ICE peaks at 46.8% thermal efficiency; WP17T methanol ICE targets heavy‑equipment energy use, cuts operating costs, and is mass‑deployed in 130‑ton mining trucks.

Intelligent driving assistance system: vehicle-road-cloud collaboration: Weichai built a vehicle‑road‑cloud full‑stack architecture, with mining autonomous solution for cm‑level docking & obstacle avoidance, and trunk‑line ADAS with intelligent cruise & auto lane‑change, boosting high‑speed safety and economy.

Going forward, Weichai will keep iterating these five tech routes with global partners to advance sustainable manufacturing.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/weichais-five-tech-routes-global-debut-diverse-paths-to-a-green-smart-future-302834548.html

SOURCE Weichai Group

Continue Reading

Technology

Portland General Electric declares dividend

Published

on

By

PORTLAND, Ore., July 24, 2026 /PRNewswire/ — The board of directors of Portland General Electric Company (NYSE: POR) declared a quarterly common stock dividend of $0.55125 per share.

The company’s dividend is evaluated based on capital requirements and financial performance. PGE targets a dividend payout ratio of 60 to 70% over the long term.

The quarterly dividend is payable on or before October 15, 2026, to shareholders of record at the close of business on September 25, 2026.

About Portland General Electric Company
Portland General Electric (NYSE: POR) is an integrated energy company that generates, transmits and distributes electricity to nearly 960,000 customers serving an area of approximately 2 million Oregonians. Since 1889, Portland General Electric (PGE) has been powering economies, delivering safe, affordable and reliable electricity while working to transform energy systems to meet evolving customer needs. PGE continues to make progress towards emissions reduction targets, and customers have set the standard for prioritizing clean energy with the No. 1 voluntary renewable energy program in the country. PGE is ranked a top ten utility in the 2025 Forrester U.S. Customer Experience Index. In 2025, PGE employees and retirees volunteered over 18,300 hours to more than 400 nonprofits organizations. Through the PGE Foundation, along with corporate contributions and the employee matching gift program, more than $5 million was directed to charitable organizations supporting economic growth and community resilience across our service area. For information: portlandgeneral.com/news.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on assumptions about the future, involve risks and uncertainties, and are not guarantees. Future results may differ materially from those expressed or implied in any forward-looking statement. These forward-looking statements represent our estimates and assumptions only as of the date of this press release. We assume no obligation to update or revise any forward-looking statement as a result of new information, future events or otherwise.

Forward-looking statements include statements, other than statements of historical or current fact, regarding the Company’s amount and timing of dividends payable as well as other statements containing words such as “committed to,” “targets,” or similar expressions.

There can be no assurance that future dividends will be declared. The declaration of future dividends is subject to approval of our board of directors and various risks and uncertainties, including, but not limited to: our cash flow and cash needs; the timing or amount of dividends paid; the timing or outcome of various legal and regulatory actions; changes in the Company’s business strategy; increases in capital expenditures; changes in capital and credit market conditions, including volatility of equity markets as well as changes in PGE’s credit ratings and outlook on such credit ratings restrictions on the payment of dividends under existing or future financing arrangements; changes in tax laws relating to corporate dividends; deterioration in our financial condition or results, and those risks, uncertainties, and other factors identified from time-to-time in our filings with the United States Securities and Exchange Commission (SEC), including our annual report on Form 10-K for the year ended December 31, 2025 and subsequent quarterly reports on Form 10-Q. These reports are available through the EDGAR system free-of-charge on the SEC’s website, www.sec.gov and on the Company’s website, investors.portlandgeneral.com. Investors should not rely unduly on any forward-looking statements. The Company assumes no obligation to update or revise any forward-looking statement as a result of new information, future events or other factors.

Media Contact:
Drew Hanson
Corporate Communications
Phone: 503-464-2067

Investor Contact:
Erin Schwartz
Investor Relations
Phone: 503-464-7751

View original content:https://www.prnewswire.com/news-releases/portland-general-electric-declares-dividend-302834503.html

SOURCE Portland General Company

Continue Reading

Trending